Real-world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study



Milojkovic, Dragana, Cross, Nicholas CP, Ali, Sahra, Byrne, Jenny, Campbell, Gavin, Dignan, Fiona L, Drummond, Mark, Huntly, Brian, Marshall, Scott, McMullin, Mary Frances
et al (show 12 more authors) (2021) Real-world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study. BRITISH JOURNAL OF HAEMATOLOGY, 192 (1). 62 - 74.

[img] Text
paper186 AAV BJH Proof 15Apr20.pdf - Accepted Version

Download (1MB) | Preview
Item Type: Article
Uncontrolled Keywords: tyrosine kinase inhibitor, chronic myeloid leukaemia, real-world study, molecular response, CML management
Depositing User: Symplectic Admin
Date Deposited: 03 Jun 2020 10:37
Last Modified: 10 Sep 2022 17:21
DOI: 10.1111/bjh.16733
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3089403